| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.002 |